Leukemia Therapeutics Market by Type (Acute, Chronic and other), Therapy (Chemotherapy, Biological Therapy, Radiation Therapy, Targeted Therapy and Others) and Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Global leukemia therapeutics market estimates USD 11.97 billion by end of 2022, growing at a CAGR of 4.1% between 2017 and 2022.

07-Mar-2017 | Number of pages: 110 | Report Code: ZMR-1272 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the leukemia therapeutics market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the leukemia therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the leukemia therapeutics market on a global level.

In order to give the users of this report a comprehensive view on the leukemia therapeutics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein type and therapy segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new therapy launch, agreements, partnerships, collaborations & joint ventures, research& development, therapy and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view on the leukemia therapeutics market by segmenting the market based on type, therapy, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on the type the market is segmented into chronic leukemia, acute leukemia and other. Chronic leukemia is further classified into chronic lymphatic leukemia and chronic myeloid leukemia.  Also, acute leukemia is further sub-segmented into acute lymphatic leukemia and acute myeloid leukemia. Based on therapy the market is segmented into chemotherapy, biological therapy, radiation therapy, targeted therapy and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for leukemia therapeutics based on individual therapy in all the regions and countries.

The report also includes detailed profiles of end players such as F. Hoffmann-La Roche Ltd., Amgen, Bristol-Myers Squibb, Novartis International AG., Pfizer, Teva Pharmaceuticals, GlaxoSmithKline plc., Genzyme Corporation,  AbbVie Inc. and ARIAD Pharmaceuticals, Inc. among others.

This report segments the global leukemia therapeutics market as follows:

Global Leukemia Therapeutics Market: Type Segment Analysis

  • Chronic leukemia
    • Chronic lymphatic leukemia
    • Chronic myeloid leukemia
  • Acute leukemia
    • Acute lymphatic leukemia
    • Acute myeloid leukemia
  • Others

Global Leukemia Therapeutics Market: Therapy Segment Analysis

  • Chemotherapy
  • Biological Therapy
  • Radiation therapy
  • Targeted therapy
  • Other

Global Leukemia Therapeutics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Computer Assisted Anesthesia Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2409 | Report Format:

Computer Assisted Anesthesia Systems Market: Overview The developments in the digital surgical methods have changed significantly one such development is the computer assisted technology systems. Among them, one of the developments is the computer assisted anesthesia systems. The computer assist...Read More

Amniotic Membrane Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2407 | Report Format:

Amniotic Membrane Market: Overview The innermost layer of the placenta that facilitates the development of the fetus during the period of pregnancy is called amniotic membrane. The amniotic membrane constitutes an avascular stromal matrix, a single epithelium layer, and a thick basement membrane...Read More

Ingestible Smart Pills Market by Component (Smart Pills and Workstation), by Application and by End-Users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Sep-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2344 | Report Format:

The report covers forecast and analysis for the ingestible smart pills market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD Million). The study includes drivers and restraints for the ingestible smart pills ma...Read More

Stem Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2340 | Report Format:

Stem Cell Banking Market: Overview Stem cells are known as building blocks of the human body. They are created in the initial stage of human development and can be found in variety of stages of development from birth till maturity. When these undifferentiated genetic cells break up, they can dis...Read More

Prostate Cancer Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2320 | Report Format:

Prostate Cancer Therapeutics Market: Overview Castration-Resistant Prostate Cancer (CRPC) is a kind of prostate cancer that characteristically comes back after administering androgen deprivation therapy(ADT); it is gaining importance in the prostate cancer market. The global CRPC market is perch...Read More

Choose License Type:
Latest Published Reports

View All Published Reports